Edition:
United States

Profile: GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

3,399.10INR
22 Jul 2016
Change (% chg)

Rs2.25 (+0.07%)
Prev Close
Rs3,396.85
Open
Rs3,397.00
Day's High
Rs3,413.95
Day's Low
Rs3,380.10
Volume
2,319
Avg. Vol
6,529
52-wk High
Rs3,872.00
52-wk Low
Rs3,032.05

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The Company's product portfolio includes prescription medicines and vaccines. The Company's prescription medicines range across therapeutic areas, and it also offers a range of vaccines for prevention of life-threatening diseases, such as pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, small pox and influenza. It provides healthcare solutions to patients, with a range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The Company's manufacturing unit is located at Nashik, and its clinical development center is located in Bangalore.

Company Address

GlaxoSmithKline Pharmaceuticals Ltd

GSK HOUSE, Dr. Annie Besant Road
MUMBAI     400030
P: +9122.24959595
F: +9122.24959494

Company Web Links